| Cormorant Asset Management, Lp |
Non-Executive |
BRIGHT MINDS BIOSCIENCES INC. (DRUG)
|
2024-11-04 |
$21.70 |
0.0% |
184,331
|
$3,999,983 |
| Cormorant Asset Management, Lp |
Non-Executive |
BRIGHT MINDS BIOSCIENCES INC. (DRUG)
|
2024-10-16 |
$7.65 |
0.0% |
422,591
|
$3,234,387 |
| Cormorant Asset Management, Lp |
Non-Executive |
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
2024-09-20 |
$20.01 |
0.0% |
350,000
|
$7,003,761 |
| Cormorant Asset Management, Lp |
Non-Executive |
EyePoint Pharmaceuticals, Inc. (EYPT)
|
2024-05-06 |
$11.86 |
-32.0% |
850,000
|
$10,081,721 |
| Cormorant Asset Management, Lp |
Non-Executive |
EyePoint Pharmaceuticals, Inc. (EYPT)
|
2024-04-18 |
$18.03 |
-55.3% |
581,765
|
$10,489,446 |
| Cormorant Asset Management, Lp |
Non-Executive |
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
2024-03-08 |
$42.41 |
19.7% |
550,000
|
$23,327,560 |
| Cormorant Asset Management, Lp |
Non-Executive |
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
2024-02-02 |
$19.00 |
167.2% |
750,000
|
$14,250,000 |
| Cormorant Asset Management, Lp |
Non-Executive |
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
2024-01-26 |
$32.24 |
57.5% |
282,632
|
$9,111,941 |
| Cormorant Asset Management, Lp |
Non-Executive |
EyePoint Pharmaceuticals, Inc. (EYPT)
|
2024-01-11 |
$19.94 |
-59.6% |
855,000
|
$17,051,100 |
| Cormorant Asset Management, Lp |
Non-Executive |
EyePoint Pharmaceuticals, Inc. (EYPT)
|
2023-12-08 |
$17.00 |
-52.6% |
588,235
|
$9,999,995 |
| Cormorant Asset Management, Lp |
Non-Executive |
EyePoint Pharmaceuticals, Inc. (EYPT)
|
2023-12-04 |
$21.82 |
-63.1% |
1,919,057
|
$41,874,151 |
| Cormorant Asset Management, Lp |
Non-Executive |
Ambrx Biopharma, Inc. (AMAM)
|
2023-10-23 |
$6.99 |
300.5% |
1,307,311
|
$9,139,542 |
| Cormorant Asset Management, Lp |
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-09-18 |
$9.12 |
207.1% |
2,152,738
|
$19,625,601 |
| Cormorant Asset Management, Lp |
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-04-20 |
$11.30 |
147.7% |
5,215,189
|
$58,950,690 |
| Cormorant Asset Management, Lp |
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-04-17 |
$9.75 |
187.3% |
2,597,896
|
$25,319,289 |
| Cormorant Asset Management, Lp |
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-03-16 |
$10.21 |
174.2% |
1,000,000
|
$10,211,400 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
74.3% |
$203,205,644 |
$273,670,565 |